Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $85.75 USD
Change Today -0.07 / -0.08%
Volume 2.4M
CAH On Other Exchanges
Symbol
Exchange
New York
Munich
As of 8:04 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

cardinal health inc (CAH) Snapshot

Open
$86.16
Previous Close
$85.82
Day High
$86.64
Day Low
$85.55
52 Week High
04/27/15 - $91.91
52 Week Low
08/8/14 - $69.66
Market Cap
28.4B
Average Volume 10 Days
3.2M
EPS TTM
$4.06
Shares Outstanding
330.8M
EX-Date
06/29/15
P/E TM
21.1x
Dividend
$1.55
Dividend Yield
1.65%
Current Stock Chart for CARDINAL HEALTH INC (CAH)

cardinal health inc (CAH) Related Businessweek News

View More BusinessWeek News

cardinal health inc (CAH) Details

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers. This segment offers distribution, inventory management, data reporting, new product launch support, and contract pricing and chargeback administration services to pharmaceutical manufacturers; operates nuclear pharmacies and cyclotron facilities that manufacture, prepare, and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; franchises retail pharmacies under the Medicine Shoppe and Medicap brands; provides pharmacy services to hospitals and other healthcare facilities; and offers logistics, marketing, and other services. This segment also provides various consulting and other services to pharmaceutical manufacturers, third-party payors, and healthcare providers. The Medical segment distributes a range of medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices, and other healthcare providers; and offers supply chain services, including spend, distribution, and inventory management services to healthcare providers. This segment also develops, manufactures, and sources a line of private brand medical and surgical products comprising surgical drapes, gowns, and apparel; exam and surgical gloves; and fluid suction and collection systems, as well as sterile and non-sterile procedure kits directly or through third-party distributors. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

35,000 Employees
Last Reported Date: 07/30/15
Founded in 1979

cardinal health inc (CAH) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.3M
Chief Financial Officer
Total Annual Compensation: $647.7K
Chief Executive Officer of Medical Segment
Total Annual Compensation: $647.7K
Chief Legal and Compliance Officer
Total Annual Compensation: $508.5K
Executive Officer
Total Annual Compensation: $756.9K
Compensation as of Fiscal Year 2014.

cardinal health inc (CAH) Key Developments

Cardinal Health, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2015; Revises Earnings Guidance for the Fiscal Year 2016

Cardinal Health, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2015. For the quarter, the company reported revenues of $27.5 billion, an increase of 20%, and non-GAAP diluted earnings per share from continuing operations of $1.00, an increase of 20% compared to revenues of $22.89 billion, and non-GAAP diluted earnings per share from continuing operations of $0.83 a year ago. Non-GAAP operating earnings increased 33% to $611 million compared to $461 million a year ago. On a GAAP basis, operating earnings increased 44% to $558 million and diluted EPS from continuing operations increased 29% to $0.88 compared to operating earnings of $387 million and diluted EPS from continuing operations $0.68 a year ago. Earnings before income taxes and discontinued operations were $523 million compared to $357 million a year ago. Earnings from continuing operations were $293 million compared to $234 million a year ago. Net earnings were $295 million or $0.88 per diluted share compared to $234 million or $0.68 per diluted share a year ago. Return on equity was 18.7% compared to 14.5% a year ago. Non-GAAP return on equity was 21.3% compared to 17.6% a year ago. The company generated $868 million in operating cash flow during the quarter. For the fiscal year 2015, revenues increased 13% to $102.5 billion, and non-GAAP diluted EPS from continuing operations increased 14% to $4.38 compared to revenues of $91.08 billion, and non-GAAP diluted EPS from continuing operations of $3.84 a year ago. Non-GAAP operating earnings increased 16% to $2.5 billion compared to $2.133 billion a year ago. On a GAAP basis, operating earnings and diluted EPS from continuing operations for fiscal year 2015 were $2.2 billion and $3.61, respectively, an increase of 15% and 7%, respectively, from the prior fiscal year. In fiscal 2015, the company generated $2.5 billion in operating cash flow and returned $1.5 billion to shareholders through dividends and share buybacks. Earnings before income taxes and discontinued operations were $1,967 million compared to $1,798 million a year ago. Earnings from continuing operations were $1,212 million or $3.61 per diluted share compared to $1,163 million or $3.37 per diluted share a year ago. Net earnings were $1,215 million or $3.62 per diluted share compared to $1,166 million or $3.38 per diluted share a year ago. Return on equity was 19.4% compared to 18.3% a year ago. Non-GAAP return on equity was 23.4% compared to 20.9% a year ago. The company revised earnings guidance for the fiscal year 2016. The company raised the midpoint of its fiscal year 2016 outlook for non-GAAP diluted EPS from continuing operations, tightening the range to $4.85 to $5.05 due to its strong fiscal year 2015 performance and the momentum the company has carried into fiscal year 2016. While the company does not provide quarterly guidance, it expects financial performance to be weighted toward the second half of fiscal 2016. The company is projecting an overall non-GAAP tax rate in the range of 35.5% to 37%.

Cardinal Health, Inc. Presents at Piper Jaffray Heartland Summit, Jun-23-2015

Cardinal Health, Inc. Presents at Piper Jaffray Heartland Summit, Jun-23-2015 . Venue: Minneapolis, Minnesota, United States. Speakers: George S. Barrett, Chairman, Chief Executive Officer and Chairman of Executive Committee.

Cardinal Health, Inc. Provides Earnings Guidance for the Fiscal 2016 and 2017

Cardinal Health, Inc. announced that as a result of planned acquisition and the pending acquisition of Cordis, the company is providing its preliminary expectations for fiscal 2016. For the period, the company expects non-GAAP diluted EPS from continuing operations of $4.75 to $5.05. This range is based on the assumptions that the THDG transaction closes in the first quarter of fiscal 2016. The accretion in non-GAAP diluted earnings per share (EPS) from continuing operations is greater than $0.15 per share in fiscal 2016, net of the $0.03 to $0.04 per share of interest expense for the related debt financing. For the fiscal 2017, Cardinal Health expects accretion in non-GAAP diluted EPS of more than $0.20 and for accretion to be increasingly greater thereafter.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CAH:US $85.75 USD -0.07

CAH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AmerisourceBergen Corp $106.21 USD +0.39
Express Scripts Holding Co $89.31 USD +0.08
Koninklijke Philips NV €25.57 EUR -0.055
Siemens AG €99.05 EUR +0.51
Walgreens Boots Alliance Inc $95.67 USD -0.24
View Industry Companies
 

Industry Analysis

CAH

Industry Average

Valuation CAH Industry Range
Price/Earnings 23.7x
Price/Sales 0.3x
Price/Book 4.5x
Price/Cash Flow 19.0x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDINAL HEALTH INC, please visit www.cardinalhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.